For treatment toxicities of grade 3 or higher, mucositis in the OCC subgroup and infection in the NOCC subgroup were the most common non-hematologic adverse effects. Neutropenia was the most commonly observed hematologic counterpart in both subgroups. With respect to the treatment outcome, the OCC ...